Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,767 | -58,125 | -43,948 | -31,504 | -22,204 |
| Depreciation Amortization | -92 | -87 | 14 | 82 | 118 |
| Accounts receivable | 39 | -36 | -10 | -88 | -896 |
| Other Working Capital | -3,434 | -3,047 | -4,086 | -4,544 | -603 |
| Other Operating Activity | 1,786 | 6,468 | 4,616 | 2,491 | 1,949 |
| Operating Cash Flow | $-18,468 | $-54,827 | $-43,414 | $-33,563 | $-21,636 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,696 | -36,483 | -44,609 | -56,685 | 14,709 |
| PPE Investments | -2 | -17 | -17 | -17 | -8 |
| Investing Cash Flow | $20,694 | $-36,500 | $-44,626 | $-56,702 | $14,701 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 263 | 87,923 | 87,740 | 87,589 | 149 |
| Financing Cash Flow | $263 | $87,923 | $87,740 | $87,589 | $149 |
| Beginning Cash Position | 10,157 | 13,561 | 13,561 | 13,561 | 13,561 |
| End Cash Position | 12,646 | 10,157 | 13,261 | 10,885 | 6,775 |
| Net Cash Flow | $2,489 | $-3,404 | $-300 | $-2,676 | $-6,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,468 | -54,827 | -43,414 | -33,563 | -21,636 |
| Capital Expenditure | -2 | -58 | -58 | -30 | -8 |
| Free Cash Flow | -18,470 | -54,885 | -43,472 | -33,593 | -21,644 |